Filana Therapeutics Inc (FLNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Operating Expenses | 30,623 | 61,402 | 19,934 | 22,789 | 27,879 |
| Operating Income | -30,623 | -61,402 | -19,934 | -22,789 | -27,879 |
| Other Income | 2,680 | 67,557 | 44,977 | 1,870 | 2,228 |
| Pre-tax Income | -27,943 | 6,155 | 25,043 | -20,919 | -25,651 |
| Net Income Continuous | -27,943 | 6,155 | 25,043 | -20,919 | -25,651 |
| Net Income | $-27,943 | $6,155 | $25,043 | $-20,919 | $-25,651 |
| EPS Basic Total Ops | -0.58 | 0.13 | 0.58 | -0.50 | -0.61 |
| EPS Basic Continuous Ops | -0.58 | 0.13 | 0.58 | -0.50 | -0.61 |
| EPS Diluted Total Ops | -0.58 | 0.13 | -0.43 | -0.50 | -0.61 |
| EPS Diluted Continuous Ops | -0.58 | 0.13 | 0.57 | -0.50 | -0.61 |
| EPS Diluted Before Non-Recurring Items | -0.58 | -1.28 | -1.41 | N/A | N/A |
| EBITDA(a) | $-30,364 | $-61,100 | $-19,623 | $-22,433 | $-27,487 |